US Speciality Formulations Invests US$15 million to Expand its Biopharma Facility in USA
Introduction:
US Speciality Formulations (USSF) invests US$15 million to expand its Lehigh Valley biopharma facility in USA.
Features:
The expansion will introduce new clean room suites and advanced automated packaging and product inspection equipment.
This will boost clean room production capacity by over 2.5 times, enabling the facility to take on significantly larger projects and support growth.
Clean rooms are critical components of a pharmaceutical facility, designed to meet stringent manufacturing standards.
They provide a highly controlled environment essential for maintaining product quality, safety, and compliance with cGMP standards. These rooms are crucial for producing sterile injectables, including small molecules, botanicals, and vaccines.
This expansion is anticipated to have a positive impact on the local economy, creating jobs and generating increased revenue for the greater Philadelphia area.
Upon completion, the facility aims to employ over 100 individuals to support operations at the Allentown facility.
The project is slated for completion by the end of 2025.
Specifications:
| Name | US Specialty Formulations |
| Type | New Construction |
| Year | 2025 |
